Projections Research

Executive Summary

Projections Research, Inc. (PRI) is a specialized scientific consulting firm that provides clinical pharmacology, pharmacometrics, and model-informed drug development (MIDD) services to pharmaceutical clients. Founded in 1990 and based in Phoenixville, PA, PRI leverages population PK/PD modeling and clinical trial simulation to optimize dose regimens, improve trial design, and accelerate regulatory submissions to agencies like the FDA and EMA. By offering data-driven insights into drug efficacy and toxicity, PRI helps sponsors reduce development timelines and increase the probability of success in clinical trials. The firm operates at the intersection of AI/machine learning and drug delivery, applying advanced quantitative methods to enhance decision-making throughout the drug development lifecycle.

Upcoming Catalysts (preview)

• Q3 2026FDA issuance of new MIDD guidance that expands the role of pharmacometrics in regulatory submissions70% success
• TBDPRI announces a major multi-year consulting contract with a top-20 pharmaceutical company50% success
• TBDExpansion of service offerings into cell and gene therapy modeling for nonclinical-to-clinical translation40% success